LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1–TINCR-USP20-PD-L1 axisQin Wang, Shouping Xu|Cell Death and Disease|2023Cited by 58
LncRNA TINCR favors tumorigenesis via STAT3–TINCR–EGFR-feedback loop by recruiting DNMT1 and acting as a competing endogenous RNA in human breast cancerQin Wang, Da Pang|Cell Death and Disease|2021Cited by 44